Health Catalyst (HCAT) 10-Q2024 Q3 Quarterly report

Filed: 6 Nov 24, 6:02pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: acclimate, accretion, agent, annum, automated, British, broken, Carevive, couple, dedicate, dedicated, deployment, digital, elastic, ERISA, essentially, flagship, foreclosure, Guarantor, hand, impracticable, inaccuracy, inorganic, instrument, intensify, lien, LLC, Lumeon, mend, menu, momentum, nonrecurring, Notable, orchestration, overnight, perfected, Pound, prepayment, quantify, ratio, refinancing, science, screening, Silver, SOFR, Subtopic, swap, threshold, trial, undrawn, Universe, unstayed, unutilized, voluntarily

Removed: customary, declaration, dynamic, extending, grace, indemnification, low, persist, PRSU, Servicing, settle, slight, subjecting, vast

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated HCAT transcripts

HCAT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Daniel Burton, Chief Executive Officer of Health Catalyst, Inc. (the “Company”), and Jason Alger, Chief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:


1			The Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024, to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and


2			The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 6, 2024



/s/ Daniel Burton
Daniel Burton
Chief Executive Officer
(Principal Executive Officer)

/s/ Jason Alger
Jason Alger
Chief Financial Officer
(Principal Financial Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.